<--- Back to Details
First PageDocument Content
Date: 2015-06-12 10:36:45

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

Add to Reading List

Source URL: posters.omed.s3.amazonaws.com

Download Document from Source Website

File Size: 650,01 KB

Share Document on Facebook

Similar Documents